Calidi Biotherapeutics Inc. (CLDI)
NYSE · Healthcare
Calidi Biotherapeutics Inc. Operating Income 2022–2022
Calidi Biotherapeutics Inc. annual/quarterly operating income history and growth rate from 2022 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Calidi Biotherapeutics Inc. annual operating income for 2022 was -23.1 M.
No data available.
Calidi Biotherapeutics Inc. Operating Income — FAQ
Calidi Biotherapeutics Inc. (CLDI) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Calidi Biotherapeutics Inc.'s operating income?
Calidi Biotherapeutics Inc. (CLDI) reported operating income of -$23M for fiscal 2022.
Where can I see CLDI's operating income history?
The chart and table above show Calidi Biotherapeutics Inc.'s operating income by year and by quarter, including the growth rate.